Clinical Trials Logo
  1. Home
  2. Primary Liver Cancer
  3. NCT05353894

Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers

Primary Liver Cancer Clinical Trial

Official title:
Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers

Clinical Trial Summary

GNS561 is a drug used in preliminary phase 1b study for treatment of patients with primary and secondary liver cancer. The formulation used was oral capsule.The objective of this study in healthy volunteers is to compare pharmacokinetics, safety and tolerability of different formulations (tablets and capsules) and dosage (50 and 200mg) of GNS561 after single oral administration in first part and to evaluate the food effect on pharmacokinetics in second part.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05353894
Study type Interventional
Source Genoscience Pharma
Contact
Status Not yet recruiting
Phase Phase 1
Start date May 2, 2022
Completion date November 30, 2022
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03161925 - Chinese Liver Cancer Clinical Survey N/A
Completed NCT00261378 - Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation Phase 2
Enrolling by invitation NCT05609448 - MRI-guided Holmium-166 Radioembolization N/A
Recruiting NCT05714124 - Liver Embolization Approaches for Tumor Management
Completed NCT03518632 - Preoperative Physical Activity Intervention in Patients Before Planned Liver Resection for Cancer (APACHE) N/A
Terminated NCT00003530 - Antineoplaston Therapy in Treating Patients With Primary Liver Cancer Phase 2
Recruiting NCT04806464 - Clinical Study of VG161 in Subjects With Advanced Primary Liver Cancer Phase 1
Recruiting NCT06342414 - An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
Completed NCT01116804 - Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC) Phase 1
Recruiting NCT03067493 - RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial Phase 2
Completed NCT05183776 - Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT N/A
Recruiting NCT05677724 - Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune Microenvironment
Not yet recruiting NCT03178929 - Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma N/A
Recruiting NCT05267080 - Registry on Percutaneous Electrochemotherapy
Not yet recruiting NCT02327819 - The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer N/A
Completed NCT01640522 - Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms N/A
Completed NCT00408122 - Evaluation of Preoperative Investigations in Patients With Liver Cancer N/A
Recruiting NCT03297255 - Primary Liver Cancer Cohort of South China N/A
Recruiting NCT06325267 - Clinical Characteristics of Primary Liver Cancer
Completed NCT04295330 - Efficacy of Intravenous Lidocaine on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy N/A